Patterns of cyclic nucleotides in normal and leukaemic human leucocytes. by Peracchi, M. et al.
Br. J. Cancer (1980) 41, 360
PATTERNS OF CYCLIC NUCLEOTIDES IN NORMAL AND
LEUKAEMIC HUMAN LEUCOCYTES
M. PERACCHI, A. T. MAIOLO, L. LOMBARDI, F. B. CATENA AND E. E. POLLI
(with the technical assistance of A. N. RESCALI)
From the First Institute of Clinical Medicine, University of Milan, Italy
Received 3 January 1979 Accepted 23 October 1979
Summary.-Because recent observations indicate that metabolism of cyclic nucleo-
tides may be altered in neoplastic cells, the intracellular levels of cyclic adenosine
3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP)
were measured in mononuclear leukaemic and normal human leucocytes. The
activities of adenylate cyclase, guanylate cyclase and cyclic nucleotide phospho-
diesterases were also determined. Under basal conditions, cAMP levels were always
higher in the normal leucocytes, whilst cGMP levels were of the same order of
magnitude in both normal and leukaemic cells, causing the cAMP/cGMP ratios to be
significantly lower in leukaemic leucocytes. Leukaemic cells significantly increased
cyclic nucleotide levels in response to theophylline, but did not respond to serotonin,
carbamylcholine or D,L-isoproterenol. Preincubation of these leucocytes with
theophylline produced a detectable cAMP response to D,L-isoproterenol but no
cGMP response to serotonin or carbamylcholine was found. Adenylate cyclase and
guanylate cyclase were significantly lower in leukaemic than in normal cells, which
could largely explain the abnormal cyclic nucleotide pattern found in human
leukaemic leucocytes. In our experiments, cAMP phosphodiesterase activity was
comparable in normal and leukaemic cells, whereas cGMP phosphodiesterase
activity was undetectable in all mononuclear-leucocyte preparations with the
methods used.
EXPERIMENTAL EVIDENCE suggests that
cyclic adenosine 3',5'-monophosphate
(cAMP) and cyclic guanosine 3',5'-mono-
phosphate (cGMP) play opposite roles in
the control of cell growth and differentia-
tion (Goldberg et al., 1975; Pastan et al.,
1975; Watson, 1975; Friedman, 1976). In
vitro, exogenous cGMP stimulates the
proliferation of fibroblasts and lymphoid
cells (Seifert & Rudland, 1974; Whitfield
et al., 1971; Diamantstein & Ulmer, 1975;
Watson, 1975) whereas cAMP, or agents
which increase its intracellular concentra-
tion, inhibit cell growth (Ryan & Heidrick,
1968; Yang & Vas, 1971; Pardee, 1974)
and induce in malignant cells a normal-
appearing morphological or biochemical
differentiation (Hsie & Puck, 1971;
Johnson et al., 1971; Prasad et al., 1975).
Moreover, low cAMP and high cGMP
levels have been found in fast-growing
cultured fibroblasts (Rudland et al., 1974;
Seifert & Rudland, 1974). Similar reduc-
tions in cAMP and/or elevations in
cGMP contents have been found in vivo
in certain spontaneous and experimentally
induced tumours (Criss et al., 1976; De
Rubertis et al., 1976; De Rubertis &
Craven, 1977; Hickie et al., 1977; Kung
et al., 1977) though this pattern has not
yet been shown to be characteristic for all
neoplastic cells.
We are not aware of any published data
on eGMP levels in leucocytes from
leukaemic patients, whereas cAMP levels
in human leukaemic cells have been re-
ported to be both decreased (Schwarz-
meier et al., 1974; Monahan et al., 1975;
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Ben-Zvi et al., 1979) and increased
(Polgar et al., 1977). As far as the enzymes
metabolizing cyclic nucleotides are con-
cerned, in leucocytes from patients with
chronic lymphocytic leukaemia (CLL)
adenylate cyclase activity was found
to be reduced, by Polgar et al. (1973)
and Sheppard et al. (1977) and cAMP
phosphodiesterase activity has been
reported to be increased by Monahan et al.
(1975) but to be decreased by Scher et al.
(1976).
The present investigation was under-
taken to obtain further information about
the cyclic nucleotide content and the
activity of the associated enzymes in
human mononuclear leucocytes from nor-
mal subjects and from patients with
chronic lymphocytic leukaemia or acute
leukaemia. In addition, the responsiveness
of the same cells to compounds which
cause cyclic nucleotide accumulation, such
as theophylline, isoproterenol, serotonin,
or carbamylcholine, was also evaluated.
MATERIALS AND METHODS
Peripheral bloodwasdrawnfrom 16healthy
volunteers, 13 patients with CLL (12 with
the B-cell type and 1 with the T-cell type of
the disease) 5 patients with acute lympho-
blastic leukaemia (ALL) and 11 patients
with acute myelogenous leukaemia (AML),
with heparin as anticoagulant. The patients
had never received therapy. Their leucocyte
countsrangedfrom 15 x 103 to 310 x 103/mm3.
The diagnosis of leukaemia was established
by complete haematological evaluation. FAB
classification (Bennett et al., 1976) was used
for the acute leukaemias. Since B lympho-
cytes are only a minor population of
normal peripheral-blood leucocytes, tonsils
from subjects undergoing tonsillectomy
for benign disease were used as a source of
B cells.
Cell isolation.-Normal mononuclear cells
were separated by centrifuging the blood on
Ficoll-Hypaque density gradients, sp. gr.
1 077 (Boyum, 1968) whilst the leukaemic
cells were isolated by spontaneous sedimenta-
tion at room temperature (Polgar et al.,
1977). The leucocytes were washed in Hanks'
medium and centrifuged many times at
100 g to remove platelets. When necessary,
red cells were lysed with 0.83% ammonium
chloride. The cells were then resuspended in
Hanks' medium at concentrations ranging from 5 x 106 to 50 x 106 cells/ml. These
preparations usually contained less than one
erythrocyte and one platelet per 5 nucleated
cells. Thepreparations ofnormal mononuclear
leucocytes contained 80-90% lymphocytes,
the remaining cells being granulocytes and
monocytes. The preparations of CLL cells
contained 79-97% lymphocytes, and those
of AML and ALL cells contained 85-100%
blasts. The percentage of T and B lympho-
cytes in CLL cell preparations was deter-
minedby E rosettes andIgstaining (Chisholm
&Tubergen, 1976; Preud'homme & Labaume,
1975). Normal granulocytes (95-99% neutro-
phils) were isolated by dextran sedimentation
of the Ficoll-Hypaque pellet resuspended in
plasma (B6yum, 1968). Platelets were isolated
by the method ofBaenziger & Majerus (1974).
Tonsil tissue was gently teased in RPMI
1640, filtered through nylon fibres, and
washed twice in RPMI 1640. B lymphocytes
were purified by the method of Greaves &
Brown (1974) by sedimentation of E rosettes
on Ficoll-Hypaque gradient. Purified pre-
parations contained less than 3% T cells and
70-90% B cells, as determined by E rosettes
and Ig staining.
All procedures for cell isolation and
purification were carried out at 40C, unless
otherwise indicated.
Cell viability, assessed by trypan-blue dye
exclusion, was always >90% for both normal
and leukaemic blood leucocytes, and always
>80% for purified tonsil B cells.
Cell incubation.-The various cell suspen-
sions were distributed into glass tubes (1 ml/
tube) and incubated at 370C in5% C02:95% aifK Preliminary experiments were per-
formed with normal mononuclear cells to
select the concentration and the incubation
time of the various drugs showing maximum
stimulation. On the basis of these results
(Fig. 1) after 10-min preincubation, 100 j,I
of Hanks' solution containing either theo-
phylline (5mM, final concentration), car-
bamycholine (100 HtM), serotonin (10 pM)
orD,L-isoproterenol (10mM)wereaddedtothe
cell suspensions. The tubes containing car-
bamylcholine were then incubated for 5 min, thosecontainingD,L-isoproterenolorserotonin
for 10 min, and those containing theophylline
for 30 min. Hanks' medium (100 ,u) was
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added to the appropriate control tubes.
Some experiments were also carried out with
CLL cells to verify whether the D,L-isopro-
terenol, carbamylcholine or serotonin concen-
trations and/or the incubation times were
critical. In addition, in order to evaluate the
influence of the phosphodiesterase activities
on intact cell responsiveness to the stimuli,
both normal and leukaemic leucocytes were
incubated with D,L-isoproterenol, carbamyl-
choline or serotonin after 20-25 min pre-
incubation with theophylline.
All the incubations were stopped by placing
the tubes in ice water.
Cyclic nucleotide extraction and assay.-The
tubes containing the cell suspensions were
centrifuged at 4°C for 10 min and the super-
natants discarded. Cyclic nucleotides were
extracted from the cell pellets in 0-7 ml
Tris-EDTA buffer (50 mm Tris/HCl, 4 mM
EDTA, pH 7.5) by boiling for 5 min and
sonication for 20 sec at 200 W (Branson cell
sonifier). The 3,500g supernatants (20 min
at 400) were lyophilized (Edwards freeze-
dryer, model EFO3).
cAMP and cGMP levels were assayed
directly in the lyophilized extracts, with the
Amersham kits. Preincubation of the cell
extracts for 1 h at 370C with cyclic nucleotide
phosphodiesterase reduced both cAMP and
cGMP levels by more than 95%. In our
assays cAMP and cGMP showed no reciprocal
interference at the concentrations in the cell
extracts. The cyclic nucleotide value for a
given case represents the mean of the
determinations for 3-5 cell extracts, assayed
at at least 2 different dilutions. The results
are expressed as pmol of cyclic nucleotide
per 107 cells.
Enzyme assays. After isolation and purifica-
tion, both normal and leukaemic cells were
resuspended at concentrations ranging from
25 x 106 to 50 x 106 cells/ml in an ice-cold
solution containing 0-25M sucrose and 50mM
Tris HCI (pH 7.5). The leucocytes were then
allowed to swell for 15 min, and sonicated for
30 sec (3 x 10 see) at 200 W or homogenized
(10 strokes) in a Dounce homogenizer.
Cyclase and phosphodiesterase activities were
usually assayed in whole extracts. In some
experiments, when guanylate cyclase was
assayed, supernatant and particulate frac-
tions of sonicates were separated by centri-
fugation at 100,000 g for 60 min; pellets were
resuspended in a volume of buffer equal to
that of the original sonicate. All procedures
were carried out at 40C. All determinations
were performed with fresh preparations.
Adenylate cvclase activity was determined
by the method of Salomon et al. (1974). The
lOO,ul assay contained 25 mm Tris HCI
(pH 7.5) 5 mm magnesium chloride, 15 mM
creatine phosphate, 37 ,tg creatine phospho-
kinase, 1 mm cAMP, 1 mM [U32P]ATP, leuco-
cyte homogenate (10-100 jig protein), and
D,L-isoproterenol (10 mM) or sodium fluoride
(10 mM) when appropriate. Incubation was
at 300C for 5-15 min in a shaker bath, and
was stopped bv the addition of 100/il of a
solution containing 2% sodium dodecylsul-
phate, 40 mm ATP and 1-4 mM cAMP at
pH 7-5. The [32P]cAMP formed was isolated
by sequential chromatography on AG50W-
X4 and alumina. [3H]cAMP (20,000 ct/min)
added before chromatography was used to
monitor cAMP recoveries, which ranged from
47 to 72%. Statistical analysis of the re-
coveries was performed after arcsin trans-
formation of the percentages (Snedecor,
1962). The coefficient of variation was
7.7% (mean 50-0, s.d. 3-83). One-way
analysis of variance showed no significant
difference between the assays (F7,232=
1-128, P>0.05). When [3H]cAMP was added
to the incubation mixture, it was found that
less than 7% of the cAMP was lost during
incubation.
Guanylate cyclase activity was assayed
according to the procedure described by De
Rubertis & Craven (1977). The incubation
mixture contained 50 mM Tris HCI (pH 7-6),
10 mM theophylline, 2-7 mm cGMP, 4 mM
manganese chloride, 15 mM creatine phos-
phate, 37 ,ug creatine phosphokinase, 1 mM
[o132P]GTP, leucocyte sonicate (10-100 ,ug
protein), serotonin (10 lM) or carbamyl-
choline (100 [LM) when appropriate, in a final
volume of 75 ,l. Incubation was at 37°C for
5-15 min, and was stopped by the addition of
20 ,ul of0-5N HCl and boiling for 1 min. After
neutralization with 0-5N NaOH in 0-IM Tris,
[3H]cGMP (20,000 ct/min in 500 )ul of water)
was added to monitor cGMP recovery. The
[32P]cGMP formed was then isolated by
sequential chromatography on AG50W-X4
and alumina. [3H]cGMP recoveries ranged
from 60 to 80%. Statistical analysis per-
formed after arcsin transformation of the
percentages gave a coefficient of variation
of 5-6% (mean 58-1, s.d. 3-25); no significant
difference between the assays was found by
one-way analysis of variance (F7,268=1-135,
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P>0 05). When [3H11 cGMP was added to the
incubation mixture, less than5% ofthe cGMP
was lost during incubation.
Both cAMP and cGMP formation were
linear with time for at least 15 min, and with
protein concentration.
Cyclic nucleotide phosphodiesterase activi-
ties were measured by Thomson & Apple-
man's 2-step procedure (1971), using 200 ltM
cAMP or 0 1 to 20 pM cGMP (200,000 ct/min
of 3H nucleotides) as substrates. Reaction
mixtures contained 40 mm Tris HCI (pH 8.0)
10 mm magnesium chloride, 3-75 mM mer-
captoethanol, 3H-labelled cyclic nucleotide,
and leucocyte sonicate (10-100 ,ug of protein)
in a final volume of 400 1lI. Incubation was
at 30°C for 30-60 min, and terminated by
boiling for 1 min. The 5'-nucleotide so formed
was then converted to the 3H-labelled nucleo-
side by treatment with snake venom. Un-
reacted nucleotide was removed by the
addition ofan anion-exchange resin (AG1-X2
slurry containing 40% methanol) and the
remaining free 3H-labelled nucleoside in the
supernatant was counted. To monitor the
loss of adenosine and guanosine through
absorption to AG1-X2 resin, 14C-adenosine
or 14C-guanosine (3,000 ct/min) were added
before treating the samples with snake
venom. Recoveries ranged from 67 to 75%
for adenosine and from 52 to 61% for
guanosine.
Alltheenzyme assays were runintriplicate.
Enzyme activities are usually expressed as
pmol of cyclic nucleotides formed or hydro-
lysed per min per mg of protein. When
guanylate cyclase was assayed in soluble and
particulate fractions, enzyme activity is
expressed as pmol of cGMP/min/107 cells.
Protein content was determined byLowry's
method.
Statistical analysis of the results was
performed by the Wilcoxon test and, when
appropriate, bytheMann-Whitney U test.
Chemicals.-[o32P]ATP (sp. act. 6-5 Ci/
mmol), [ox32P]GTP (sp. act. 4.3 Ci/mmol),
[3H]cAMP (sp. act. 20 Ci/mmol), [3H]cGMP
(sp. act. 20 Ci/mmol), 14C adenosine (sp. act.
58 mCi/mmol), 14C-guanosine (sp. act. 562
mCi/mmol), cAMP assay kit (code TRK 432)
and cGMP RIA kit (code TRK 500) were
obtained from The Radiochemical Centre,
Amersham, Bucks, Ficoll-Hypaque, RPMI
1640, and Hanks' solution were purchased
from Eurobio,Paris,France;carbamylcholine,
theophylline and serotonin creatine sulphate
from BDH Chemicals Ltd, Poole; D,L-isopro-
terenol monohydrochloride, cyclic 3',5'-
nucleotide phosphodiesterase, creatine phos-
phate, creatine phosphokinase, cAMP, cGMP,
ATP, GTP, snake venom (Ophiophagus
hannan) dextran (mol. wt 200,000-275,000)
and alumina from Sigma Chemical Co., St
Louis, Mo, U.S.A.; Dowex AG1-X2 (200 to
400 mesh, Cl-) and Dowex AG50W-X4 (200
to 400 mesh, H+) from Bio Rad Laboratories,
Richmond, Calif., U.S.A. Antihuman IgG
(y chain), IgA (of chain), IgM (I chain), IgD
(S chain) fluorescein conjugated from Beh-
ringwerke A.G., Marburg, West Germany.
All other chemicals were of commercial
analytical grade quality.
RESULTS
As shown in Tables I and II, all the
different types of human leukaemic leuco-
cytes have similar cyclic nucleotide pat-
terns. However, a major problem in the
evaluation of these results concerns the
validity ofthe normal controls. At present,
for technical reasons, normal human
lymphoblasts and myeloblasts are not
available forstudy, and normal peripheral-
blood leucocytes do not provide an appro-
priate control for ALL and AML cells.
Moreover, the comparison between normal
peripheral-blood mononuclear leucocytes
and cells from CLL patients, although
widespread in the literature, may also be
criticized on the ground that CLLlympho-
cytes are usually B cells, while lympho-
cytes from normal subjects are a mixture
ofB and T cells.
In this study, cyclic nucleotide levels
were determined both in normal-blood
mononuclear leucocytes and in B lympho-
cytes isolated from tonsils of normal sub-
jects. Cyclic nucleotide patterns were also
studied in purified preparations of normal
granulocytes and platelets, since con-
tamination with these cells was found in
blood mononuclear leucocyte prepara-
tions. Under basal conditions, the cAMP
and cGMP contents (pmol/107 cells) were
respectively 3-24 + 0-71 and 0-76 + 0-06
(mean + s.e.) for granulocytes (7 cases),
and 0-18 + 0*026 and 0 03 + 0-004 for
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TABLE I.-cAMP levels in human mononuclear leUCocytes from normal and leukaemic
subjects (means + s.e.)
cAMP pmol/107 cells
, ~~~~~~A- I
D,L-
isoproterenol
Control 10 mm
10 min 10 min
Theophylline
Control 5 mM
30 min 30 min
Normal peripheral-blood
mononuclear leucocytes
(16 cases)
Normal tonsil B lymphocytes
(6 cases)
CLL B lymphocytes
(12 cases)
CLL T lymphocytes
(1 case)
ALL leucocytes
(5 cases)
AML leucocytes
(11 cases)
21-9+1-53 76-i
12-8 + 1-03t 33-E
P=
7-0+2-15$ 8-'
7-5
9+9-12 22-8+2-32 53-5+5-04
I 0.01* P < 0-01*
8 + 3-38 12-3 + 0-93t 20-9 + 2-52
=0.05* P=0.05*
2+1-90 6-7+2-121 11-5+3-14
N.S.* P<0*01*
7*4 7-7 14-7
4-2+0-89 9-1+5-16
5-3+0-75 10-4+2-45
N.S.*
4-1+0-86 5-6+1-46
5-4+0-74 11-1 + 1-79
P<0-01*
* VS control, Wilcoxon test.
t P < 0-02 vS normal peripheral-blood mononuclear leucocytes, Mann-Whitney U test.
I P < 0-02 V8 normal tonsil B lymphocytes, Mann-Whitney U test.
TABLE II.-cGMP levels in human mononuclear leucocytes from normal and leukaemic
subjects (means + s.e.)
cGMP pmol/107 cells
t --1--
Carbamyl-
Serotonin choline
Control 10 /AM 100 ItM
10 min 10 min 5 min
Normal peripheral-blood
mononuclear leucocytes 1-06 + 0-05
(16 cases)
Normal tonsil B lymphocytes 0-57 + 0-08t
(6 cases)
CLL B lymphocytes 0-43 + 0-051
(11 cases)
CLL T lymphocytes 0-46
(1 case)
ALL leucocytes
(5 cases)
AML leucocytes
(11 cases)
0-78 + 0-23
1-73+0-15
P <0-01*
0-80+ 0-12
P=0-05*
0-45 +0-05
N.S.*
0-47
0-83+0-22
0-56+0-09 0-62+0-12
N.S.*
1-83+0-17
P<0-01*
0-75 + 0-06
P=0-05*
0-45+0-05
N.S.*
0-46
Theophylline
Control 5 mM
* 30 min 30 min
1-10+0-06 3-42+0-30
P<0-01*
0 0-54+0-09t 1-37+0-11
P=0-05*
0-42 +0-06t 0-94 + 0-07
P<0-01*
0-49 0-82
0-75+0-19 1-56+0-34
0-58+0-09 1-22+0-12
P<0.01*
* vw control, Wilcoxon test.
t P < 0-02 vs normal peripheral-blood mononuclear leucocytes, Mann-Whitney U test.
$ N.S. vs normal tonsil B lymphocytes.
platelets (5 cases); our standard stimuli interference from cyclic nucleotides of
produced a statistically significant in- granulocyte or platelet origin was
crease in these levels. Under our experi- negligible.
mental conditions, granulocyte contami- Without stimulation, tonsil B lympho-
nation was generally less than 5% of the cytes had both cAMP and cGMP levels
leucocytes, whilst platelets were not in- significantly lower than those of periph-
cluded in leucocyte counts. Therefore, eral-blood mononuclear cells (Tables I
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and 11). However, the cAMP/cGMP molar
ratio was similar in both the normal
leucocyte preparations.
Statistical comparison of the data was
performed only between CLL and normal
B lymphocytes. cAMP levels were sig-
nificantly higher in normal than in leuk-
aemic cells, whilst cGMP concentration
was similar in normal and CLL lympho-
cytes. The cAMP/cGMP ratio was 23-2 +
3-40 in tonsil lymphocytes and 12-1 + 3-15
in CLL cells (P < 0.05). Even lower molar
a
0
U
0
U
a3
N
0.
49
a
ratios were found in acute-leukaeemia
leucocytes (6-1 + 1-16 for ALL cells and
9-5 + 1-76 for AML cells).
From Tables I and II it is also evident
that the intact normal leucocytes were
sensitive to the stimulating effects of D,L-
isoproterenol, serotonin, carbamyleholine
and theophylline. Leucocytes from
patients with either CLL, ALL or AML
significantly increased both cAMP and
cGMP levels in response to theophylline,
but failed to respond significantly to the
CARSAMYLCHOLINE
s min IncubetIn mole.ity 10
@2 $10o
to min ncubetton
SEROTONIN
A mowi-rtyi
02_ 1
__o'W
.. .
ISOPROTERENOL
obrity.102
NORMALW3 CLL(sW CLL*
MOLARITY INCUBATION TIME WMIN)
IG. 1.Cyc---tycli(c nucleotide responses, in normal andl CLL hluman leucocytes, to 1),L-isoproterenol,
serotonin and carbamyclholine, adde(d at the inditated concentrations and times. The number of cases is in(licated in brackets. Data are expressed as means + s.e.
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FIG. 2.-Effect of preincubation with theo-
phylline (Theo) on cAMP response to D,L-
isoproterenol (Iso) and on cGMP response
to serotonin (Sero) and carbamylcholine
(Carba) in normal and leukaemic human
mononuclear leucocytes. The number of
cases is indicated in brackets. Data are
expressed as means + s.e. Statistical
analysis by Wilcoxon test.
other stimuli. Serotonin (10 uM) and
carbamylcholine (100 guM) were com-
pletely ineffective in raising the cGMP
levels in any of the leukaemic cells tested
(Table II). The effects of these drugs in
CLL cells were then checked over a wide
range of incubation times and of molar
concentrations, and again no cGMP
accumulation was found (Fig. 1). D,L-
isoproterenol was also generally ineffective
in raising the cAMP levels in leukaemic
cells (Table I). However, in the blasts
from 2/11 AML patients and from 1/5
ALL patients a 3- to 5-fold increase in
cAMP content was found. In CLL cells,
no cAMP accumulation was found when
D,L-isoproterenol effects were studied over
a wide range of incubation times and of
molar concentrations (Fig. 1).
As slhown in Fig. 2, normal-blood mono-
nuclearleucocytes afterpreincubationwith
theophylline vere still able to respond to
D,L-isoproterenol, serotonin or carbamyl-
choline. Leukaemic cells, unresponsive to
D,L-isoproterenol alone, displayed a sig-
nificant cAMP accumulation in response
to this stimulus when they had been pre-
incubated with theophylline. By contrast,
the cGMP levels were essentially the same
in the leukaemic cells incubated either
with theophylline or with theophylline
plus serotonin or plus carbamylcholine.
Cyclase and phosphodiesterase activities
in whole extracts of normal leucocytes,
CLL cells and AML cells are summarized
in Tables III and IV. Enzyme activity
TABLE IV.-Soluble andparticulate guanyl-
ate cyclase activity in human mononuclear
leucocytes from normal and leukaemic
subjects (means +s.e.)
Normal
peripheral-blood
mononuclear
leucocytes
(3 cases)
Normal tonsil
B lymphocytes
(1 case)
CLL
B lymphocytes
(3 cases)
CLL
T lymphocytes
(1 case)
Guanylate cyclase
(pmol cGMP/min/107 cells)
100,000 g
Whole super- 100,000 g
sonicate natant pellet
13-2+1-19 97+0-94 1-3+0-08
(74)* (10)
12-4 11.0
(89)
1-5
(12)
6-4+0 39 4-3+0 45 1-4+0 50
(68) (20)
6-7 4.7 1-3
(70) (19)
* Values in parentheses are the mean percentage
of the whole sonicate activity.
patterns were similar in both normal tonsil
B lymphocytes and normal peripheral-
blood mononuclear leucocytes (Table III);
therefore, CLL cells were compared with
normal-blood mononuclear leucocytes,
since the number of tonsil B lvmphocyte
preparations was insufficient for statistical
comparison.
3
2
Itb
1
a CoI
0 75
% 50
A.
U9
U
Ia _ I .-Z- ----- -
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Under basal conditions, CLL cells had
both adenylate cyclase and guanylate
cyclase activities similar to those of AML
cells, and significantly lower than those of
normal leucocytes. Since guanylate cyclase
is both soluble and particulate, enzyme
activity was also assaved in the 100,000 g
supernatant and pellet fractions of normal
and leukaemic leucocyte sonicates. As
shown in Table IV, most of the guanylate
cyclase activity of sonicates xvas found in
the supernatant fractions of both normal
and leukaemic cells. However, the enzyme
activity found in the particulate fractions
was generally higher in CLL than in
normal-leucocyte preparations.
From Table III it is evident that the
adenylate cyclase responses to NaF were
similar in both normal and leukaemic
leucocytes, while the responses to D,L-
isoproterenol was markedly lower in leuk-
aemic than in normal cells. Serotonin and
carbamylcholine did not significantly
modify the guanylate cyclase activity in
either normal or leukaemic cells. The mean
cAMP phosphodiesterase activity was
slightly higher in CLL than in normal
leucocytes, but this difference was not
statistically significant. When leucocyte
cAMP phosphodiesterase activity was
studied at varying substrate concentra-
tions (1.0-200 pm), the Km values ob-
tained were 0 94 and 98 [M for the enzyme
from normal mononuclear cells and 1-24
and 100 pm for the enzyme from CLL cells.
Under our experimental conditions,
cGMP phosphodiesterase activity was very
low and usually undetectable (less than
2 pmol of cGMP hydrolysed/60 min/50 jg
of protein) in either normal or leukaemic
cells. However, 3 preparations, one of CLL
lymphocytes and 2 of normal mono-
nuclear leucocytes, showed measurable
cGMP hydrolytic activity (5 7, 7-8 and 9*6
pmol/min/mg of protein, respectively).
Platelet contamination of these prepara-
tions might perhaps account for these
results, since in our experiments cGMP
phosphodiesterase activity in purified pre-
parations of platelets was 905 + 46*9
pmol/min/mg ofprotein.
]DISCUSSION
Normal leucocytes
Intracellular cyclic nucleotide levels
have been widely studied in leucocytes
from human peripheral blood (Illiano et
al., 1973; Parker & Smith, 1973; Bourne
et al., 1973; Parker et al., 1974; Sandler et
al., 1975; Goldberg & Haddox, 1977;
Atkinson et al., 1977; Polgar et al., 1977;
Takemoto et al., 1978). However, only a
few data have been reported on cyclic
nucleotide patterns in purified prepara-
tions of human T and B lymphocytes.
Atkinson et al. (1977) found lower cAMP
levels in T lymphocytes than in mixed
lymphocytes isolated from peripheral
blood, while Scher et al. (1976) failed to
demonstrate any significant difference in
cAMP phosphodiesterase activities be-
tween normal B- and T-lymphocyte sub-
populations. Our results indicate that both
cAMP and cGMP levels are lower in tonsil
B lymphocytes than in peripheral-blood
mononuclear leucocytes. However, there
was no difference in the cells' cyclic
niucleotide responsiveness to the stimuli,
and cyclase and phosphodiesterase pat-
terns were similar in both normal leuco-
cyte preparations.
In recent years, a large amount of in-
formation about cAMP metabolism in
human leucocytes has been accumulated
(see above). In contrast, little is known
about the control mechanisms for cGMP
content in these cells, although guanylate
cyclase&activity has been found in human
peripheral lymphocytes (Deviller et al.,
1975).
In our experiments, 2 possible stimuli
for guanylate cyclase, serotonin and
carbamylcholine, which increased the
cGMP level in intact normal leucocytes,
failed to modify this enzyme activity in
broken-cell preparations. This is con-
sistent with previously reported data
which have generally indicated that no
changes in guanylate cyclase activity were
found when hormones or other biologically
active substances were added to various
cell homogenates (Goldberg & Haddox,
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1977). However, the possibility that
serotonin and carbamylcholine enhanced
cellular cGMP accumulation by mech-
anisms other than guanylate cyclase
activation cannot be excluded on the basis
ofour data.
Under our experimental conditions, no
cGMP phosphodiesterase activity was
found in normal leucocyte preparations,
thus confirming previous data reported by
Thompson et al. (1976) and Takemoto
(1978). However, the intact cells signifi-
cantly increased their cGMP content when
incubated with theophylline, a known
inhibitor of phosphodiesterase activity.
Therefore, the possibility cannot be ex-
cluded that cGMP-hydrolytic activity may
be present in human leucocytes, though
not measurable by the methods used.
Alternatively, the effects of theophylline
on cGMP accumulation in human leuco-
cytes might be explained by the ability of
the methylxanthines to increase intra-
cellular calcium levels (McNeill et al., 1968)
which are well known to modulate cGMP
content (Schultz et al., 1973; Goldberg &
Haddox, 1977).
Leukaemic leucocytes
Our results with leukaemic cells must
be interpreted with great caution, since no
data are at present available on cyclic
nucleotide pattern in normal human
myeloblasts and lymphoblasts for com-
parison with leucocytes from patients with
acute leukaemias. In addition, even when
seemingly appropriate controls are avail-
able, as in the case of normal B lympho-
cytes for CLL B lymphocytes, the differ-
ences observed are not necessarily a
correlate of leukaemia per se, but could be
related to other factors, such as the degree
of cell rnaturation. With these limitations
in the interpretation ofthe results in mind,
our investigation showed that in human
leukaemias the cell patterns of cyclic
nucleotides are different from those in
normal cells. A difference was already
detectable in the unstimulated levels of
cAMP and eGMP. Leucocytes from CLL
patients had cAMP levels markedly lower
than those found in normal B lymphocytes
and in normal mononuclear cells, and a
relative prevalence of cGMP over cAMP
was present in these leukaemic cells.
A further dissimilarity between cyclic
nucleotide patterns in normal and leuk-
aemic cells became evident after stimula-
tion or inhibition ofthe pertinent enzymes.
A virtually constant feature of the humain
leukaemic leucocytes was the failure of
cyclic nucleotides to respond to serotonin,
carbamylcholine and D,L-isoproterenol,
while still responding to theophylline. Our
data agree with the findings ofPolgar et al.
(1977) who showed that cAMP levels in
CLL lymphocytes had reduced responses
to isoproterenol, prostaglandins and
epinephrine.
It is obvious that cAMP behaviour in
leukaemic cells can be correlated in large
part with the defective adenylate cyclase
activity also found by others (Polgar et al.,
1973; Sheppard et al., 1977). Furthermore,
the decreased responsiveness of adenylate
cyclase to catecholamine in CLL lympho-
cytes was found to be associated with a
reduction in 3-adrenergic receptor sites
(Sheppard et al., 1977). However, the
presence of this lesion at the membrane
level cannot explain all the abnormalities
of cAMP metabolism we have found. In
our experiments, preincubation with theo-
phylline allowed cAMP accumulation by
isoproterenol in leukaemic cells, thus sug-
gesting an excessive phosphodiesterase
activity also. cAMP-phosphodiesterase
activity in CLL and AML cells was com-
parable to thatfound in normal leucocytes.
However, the levels of phosphodiesterase
activity are disproportionately high when
compared to the low adenylate cyclase
activity of these cells. In addition, a con-
sistent qualitative difference in cAMP
phosphodiesterase between normal and
leukaemic human lymphocytes has also
been reported by Takemoto et al. (1978)
who demonstrated that cGMP at juM con-
centrations clearly inhibited the cAMP
phosphodiesterase activity in normal but
not in leukaemic cells.
This stuidy clearly (lemonstrates that
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there are also complex alterations in
cGMP metabolism in peripheral human
leukaemic cells. The observation that
serotonin and carbamylcholine were un-
able to increase cGMP levels in leukaemic
leucocytes, either alone or in the presence
of theophylline, cannot be explained only
as the consequence of an abnormal cGMP
degradation mechanism, but implies that
there is also an alteration in guanylate
cyclase. In our experiments, total guanyl-
ate cyclase activity was significantly lower
in leukaemic than in normal Jeucocytes.
However, a relative increase in the activity
of the particulate enzyme was found in
CLL cells.
The significance ofthe alterations in the
guanylate cyclase-cGMP system in leuk-
aemic leucocytes remains to be deter-
mined. Guanylate cyclase activity is
generally increased in malignancy (De
Rubertis & Craven, 1977; Kumakura et al.,
1977; Boyd et al., 1978). However, reduc-
tions in total guanylate cyclase, with a
relative predominance of the particulate
form of enzyme activity, have been found
in some Morris hepatomas and renal
tumours (Criss et al., 1976; Hickie et al.,
1977) suggesting a relationship between
cell proliferation and changes in the sub-
cellular distribution of the enzyme.
The clinical implications ofthe derange-
ments in cyclic nucleotide metabolism in
leukaemic cells are still unknown. Since it
is thought that a relationship may exist
between the cyclic nucleotide system and
the processes of cell proliferation and
differentiation, further studies should be
carried out, in the hope of attaining a
better understanding of the pathogenesis
ofhuman leukaemias.
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